Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: A case-control study

Leukemia

Volumn 21, Issue 2, 2007, Pages 320-325

  Gast, A ^a   Bermejo, J L ^a   Flohr, T ^b   Stanulla, M ^c   Burwinkel, B ^a   Schrappe, M ^d   Bartram, C R ^b   Hemminki, K ^a,e   Kumar, R ^a,e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; FOLIC ACID; GUANINE; THYMINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; FOLATE METABOLISM; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION;

EID: 33846537961     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404474     Document Type: Article

References (34)

1. Canalle R, Burim RV, Tone LG, Takahashi CS. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 2004; 43: 100-109.
2. Greaves MF. Aetiology of acute leukaemia. Lancet 1997; 349: 344-349.
3. Meier M, den Boer ML, Hall AG, Irving JA, Passier M, Minto L et al. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia. Leukemia 2005; 19: 1887-1895.
4. Zeller B, Gustafsson G, Forestier E, Abrahamsson J, Clausen N, Heldrup J et al. Acute leukaemia in children with Down syndrome: A population-based Nordic study. Br J Haematol 2005; 128: 797-804.
5. McNally RJ, Eden TO. An infectious aetiology for childhood acute leukaemia: A review of the evidence. Br J Haematol 2004; 127: 243-263.
6. Couto E, Chen B, Hemminki K. Association of childhood acute lymphoblastic leukaemia with cancers in family members. Br J Cancer 2005; 93: 1307-1309.
7. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: Lessons in natural history. Blood 2003; 102: 2321-2333.
8. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006; 6: 193-203.
9. Cheok MH, Evans WE. Acute lymphoblastic leukaemia: A model for the pharmacogenomics of cancer therapy. Nat Rev Cancer 2006; 6: 117-129.
10. Pakakasama S, Mukda E, Sasanakul W, Kadegasem P, Udomsubpayakul U, Thithapandha A et al. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol 2005; 79: 202-205.
11. Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005; 105: 4752-4758.
12. Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 2002; 97: 230-236.
13. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999; 96: 12810-12815.
14. Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: A Huge minireview. Am J Epidemiol 2003; 157: 571-582.
15. Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004; 103: 252-257.
16. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002; 99: 3786-3791.
17. Thirumaran RK, Gast A, Flohr T, Burwinkel B, Bartram C, Hemminki K et al. MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood 2005; 106: 2590-2591, author reply 2591-2592.
18. Schnakenberg E, Mehles A, Cario G, Rehe K, Seidemann K, Schlegelberger B et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet 2005; 6: 23.
19. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999; 55: 997-1004.
20. Thirumaran RK, Bermejo JL, Rudnai P, Gurzau E, Koppova K, Goessler W et al. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 2006; 27: 1676-1681.
21. Westfall PH, Young SS. Resampling-Based Multiple Testing. John Wiley & Sons: New York, 1993, pp. 1-360.
22. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.
23. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE review. Am J Epidemiol 2004; 159: 423-443.
24. Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004; 13: 787-794.
25. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001; 157: 451-456.
26. Zavadakova P, Fowler B, Suormala T, Novotna Z, Mueller P, Hennermann JB et al. cblE type of homocystinuria due to methionine synthase reductase deficiency: Functional correction by minigene expression. Hum Mutat 2005; 25: 239-247.
27. Wilson A, Leclerc D, Rosenblatt DS, Gravel RA. Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. Hum Mol Genet 1999; 8: 2009-2016.
28. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW et al. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003; 12: 1222-1226.
29. Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR et al. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: A case-control analysis. Pharmacogenet Genomics 2005; 15: 547-555.
30. Zhang Z, Shi Q, Liu Z, Sturgis EM, Spitz MR, Wei Q. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: A case-control analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 1188-1193.
31. Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR et al. Methionine synthase reductase 66A →G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C →T variant. J Nutr 2004; 134: 2985-2990.
32. de Jonge R, Hooijberg JH, van Zelst BD, Jansen G, van Zantwijk CH, Kaspers GJ et al. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. Blood 2005; 106: 717-720.
33. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med 2005; 56: 303-320.
34. Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002; 99: 8242-8247.